Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health Inc has demonstrated significant financial growth, with last twelve months (LTM) calculated billings increasing nearly 44% year-over-year to $671 million and a client count rising by 25% to over 2,800, indicating strong market demand and retention. The company reported revenue of $170.7 million, reflecting a 46% year-over-year increase, which surpassed both consensus estimates and prior predictions, highlighting its robust operational performance. Looking forward, Hinge Health's guidance for 2026 suggests further expansion potential, projecting revenue growth that outpaces analyst expectations, reinforcing a positive outlook on its market position and financial health.

Bears say

The analysis of Hinge Health Inc indicates concerns over its future performance, primarily linked to a projected macro-driven weak spending environment in the second half of 2025, which may lead to slower than anticipated growth in fiscal year 2026. While the company has shown strong non-GAAP gross and operating margins compared to consensus estimates, the prevailing economic conditions could hinder its ability to maintain revenue growth, particularly due to its reliance on employee utilization for billings. Additionally, competition dynamics suggest that budget constraints are causing potential clients to delay decisions, posing a significant risk to Hinge Health's revenue generation in the upcoming periods.

HNGE has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 17 analysts, HNGE has a Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $58.65, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $58.65, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.